Protocol First joins Flatiron Health to advance clinical research. Read more
EP 03 | Bridging the divide: Opportunities to integrate clinical research into everyday care
In 2016, the Leukemia and Lymphoma Society (LLS) established the Beat AML® trial with the aim of advancing the treatment paradigm for AML through collaboration across over 20+ sites, sponsors, and technology vendors.
In order to effectively run the coordination needed for this large master protocol, LLS sought a technology partner with capabilities to (1) enable remote access to source data, (2) facilitate data entry with EHR-to-EDC technology, and (3) provide an EDC system that can be seamlessly updated. LLS partnered with Flatiron (formerly Protocol First) to provide multiple eClinical solutions to meet the high demands and standards for Beat AML® with great success.
Read more about how innovative clinical trial technology helped enable the Beat AML® trial.
Source Upload, Clinical Pipe and P1 EDC
major Academic centers
Prospective Clinico-Genomic Study
Flatiron Health, Foundation Medicine and Genentech partnered to develop a novel, low-interventional prospective study for patients living with advanced lung cancer 一 PCG. This study piloted the use of a technology-enabled prospective data collection platform and aimed to alleviate clinical trial operational challenges.
Read the full case study to learn more about Flatiron’s approach to Prospective Real-World Studies.
There’s a lot of human error components that can come with that when you’re moving a lot of data points, and you’re having to answer a lot of queries which also take time. For us, this is the first technology solution we’ve been presented with that really takes everything off the site.